Research Output per year
Fingerprint Dive into the research topics where Secondo Lastoria is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 19 Similar Profiles
Radionuclide Imaging
Medicine & Life Sciences
Neoplasms
Medicine & Life Sciences
Rectal Neoplasms
Medicine & Life Sciences
Octreotide
Medicine & Life Sciences
Therapeutics
Medicine & Life Sciences
Melanoma
Medicine & Life Sciences
Radiotherapy
Medicine & Life Sciences
Neoplasm Metastasis
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output 1981 2019
18F-FDG PET/CT Is an Early Predictor of Pathologic Tumor Response and Survival to Preoperative Radiochemotherapy with Bevacizumab in High Risk Locally Advanced Rectal Cancer
Avallone, A., Aloj, L., Pecori, B., Caraco, C., De Stefano, A., Tatangelo, F., Silvestro, L., Granata, V., Bianco, F., Romano, C., Di Gennaro, F., Budillon, A., Petrillo, A., Muto, P., Botti, G., Delrio, P. & Lastoria, S., 2019, In : Journal of Nuclear Medicine.Research output: Contribution to journal › Article
Fluorodeoxyglucose F18
Chemoradiotherapy
Rectal Neoplasms
Survival
Neoplasms
Costs of clinical trials with anticancer biological agents in an Oncologic Italian Cancer Center using the activity-based costing methodology
Pascarella, G., Capasso, A., Nardone, A., Triassi, M., Pignata, S., Arenare, L., Ascierto, P., Curvietto, M., Maiolino, P., D’Aniello, R., Montanino, A., Laudato, F., De Feo, G., Botti, G., Perrone, F., Petrillo, A., Cavalcanti, E., Lastoria, S., Maurea, N. & Morabito, A., Jan 1 2019, In : PLoS One. 14, 1, e0210330.Research output: Contribution to journal › Article
Biological Factors
Antineoplastic Agents
clinical trials
Clinical Trials
Costs and Cost Analysis
Italian expert panel consensus statement on the optimal use of PD-1 blockade therapy in classical Hodgkin lymphoma
Zinzani, P. L., Santoro, A., Chiti, A., Lastoria, S., Pinto, A., Rigacci, L., Barosi, G., Pennisi, M. & Corradini, P., May 2019, In : Leukemia and Lymphoma. 60, 5, p. 1204-1213 10 p.Research output: Contribution to journal › Article
Hodgkin Disease
Blocking Antibodies
Stem Cell Transplantation
Therapeutics
Uncertainty
Italian expert panel consensus statement on the optimal use of PD-1 blockade therapy in classical Hodgkin lymphoma
Zinzani, P. L., Santoro, A., Chiti, A., Lastoria, S., Pinto, A., Rigacci, L., Barosi, G., Pennisi, M. & Corradini, P., Jan 1 2018, In : Leukemia and Lymphoma.Research output: Contribution to journal › Article
Hodgkin Disease
Blocking Antibodies
Stem Cell Transplantation
Therapeutics
Uncertainty
1
Citation
(Scopus)
Italian expert panel consensus statement on the optimal use of PD-1 blockade therapy in classical Hodgkin lymphoma
Zinzani, P. L., Santoro, A., Chiti, A., Lastoria, S., Pinto, A., Rigacci, L., Barosi, G., Pennisi, M. & Corradini, P., Jan 1 2018, (Accepted/In press) In : Leukemia and Lymphoma.Research output: Contribution to journal › Article
Hodgkin Disease
Blocking Antibodies
Stem Cell Transplantation
Therapeutics
Uncertainty